TY - JOUR
T1 - A Descriptive Study of Drug-induced Clostridium difficile
AU - Ahmed, Nehad
AU - Alamer, Ahmad
AU - Almalki, Ziyad
AU - Alshehri, Ahmed
AU - Alahmari, Abdullah
N1 - Publisher Copyright:
© 2022, Colegio de Farmaceuticos de la Provincia de Buenos Aires. All rights reserved.
PY - 2022
Y1 - 2022
N2 - SUMMARY. The most common pathogen responsible for diarrhea connected with healthcare is Clostridium difficile. There are several causes of its occurrence but the greatest significant risk factor for the development of C. difficile infection is antibiotic exposure. The present study aimed to describe the reports of drug-induced C. difficile using the FAERS database. During the study period, 29095 reports were submitted to FAERS. The most reported drugs were adalimumab (5.60%), infliximab (4.07%), lenalidomide (3.73%), cefuroxime axetil (3.46%), prednisone (3.14%), cyclophosphamide (3.14%), metronidazole (3.05%), amoxicillin\clavulanate potassium (2.71%), and ciprofloxacin (2.63%). C. difficile infection may be avoided if the right antibiotic treatment is chosen, and infection control procedures are followed.
AB - SUMMARY. The most common pathogen responsible for diarrhea connected with healthcare is Clostridium difficile. There are several causes of its occurrence but the greatest significant risk factor for the development of C. difficile infection is antibiotic exposure. The present study aimed to describe the reports of drug-induced C. difficile using the FAERS database. During the study period, 29095 reports were submitted to FAERS. The most reported drugs were adalimumab (5.60%), infliximab (4.07%), lenalidomide (3.73%), cefuroxime axetil (3.46%), prednisone (3.14%), cyclophosphamide (3.14%), metronidazole (3.05%), amoxicillin\clavulanate potassium (2.71%), and ciprofloxacin (2.63%). C. difficile infection may be avoided if the right antibiotic treatment is chosen, and infection control procedures are followed.
KW - adverse event reporting
KW - Clostridium colitis
KW - Clostridium difficile
KW - FAERS
UR - http://www.scopus.com/inward/record.url?scp=85141364826&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:85141364826
SN - 0326-2383
VL - 41
SP - 2303
EP - 2306
JO - Latin American Journal of Pharmacy
JF - Latin American Journal of Pharmacy
IS - 11
ER -